Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03368729 |
Title | Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer |
Recruitment | Recruiting |
Gender | female |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | University of Alabama at Birmingham |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Alabama at Birmingham | RECRUITING | Birmingham | Alabama | 35294 | United States | Details |
University of Chicago | RECRUITING | Chicago | Illinois | 60637 | United States | Details |
Mayo Clinic | NOT_YET_RECRUITING | Rochester | Minnesota | 55905 | United States | Details |
Montefiore | RECRUITING | Bronx | New York | 10461 | United States | Details |
University of North Carolina | RECRUITING | Chapel Hill | North Carolina | 27599 | United States | Details |
University of Pennsylvania | NOT_YET_RECRUITING | Philadelphia | Pennsylvania | 19104 | United States | Details |
University of Washington- | RECRUITING | Seattle | Washington | 98109 | United States | Details |